Novartis AG - Total Other Income Expense Net

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -1.14 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

Novartis AG's third quarter result of -0.305 Billion USD for the item "Total Other Income Expense Net" represents an increase of 8.41 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of -0.305 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -26.03 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -1.14 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -5.86 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.275 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.275 Billion United States Dollars.
The 3 year change is -14.92 Billion United States Dollars.
The 5 year change is -0.886 Billion United States Dollars.
The 10 year change is -1.25 Billion United States Dollars.

The Serie's long term average value is 1.18 Billion United States Dollars. It's latest available value, on 09/30/2025, is -2.32 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2021, to it's latest available value, on 09/30/2025, is -15.59 Billion.